Paloma Partners Management CO Biogen Inc. Call Options Transaction History

Paloma Partners Management CO

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $132,724 - $167,586	626 Added 36.82%	2,326 $501,000
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $378,403 - $455,498	1,700 New	1,700 $439,000
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $1.77 Million - $2.02 Million	6,900 New	6,900 $1.92 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $175,221 - $241,613	900 New	900 $240,000
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $569,052 - $753,610	-2,200 Reduced 91.67%	200 $54,000
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $349,505 - $443,352	-1,300 Reduced 35.14%	2,400 $759,000
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $21,929 - $24,172	100 Added 2.78%	3,700 $865,000
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $362,050 - $458,575	1,300 Added 56.52%	3,600 $1.08 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $7.04 Million - $9.21 Million	-24,000 Reduced 91.25%	2,300 $813,000
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $2.32 Million - $2.76 Million	-9,000 Reduced 25.5%	26,300 $7.63 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $4.92 Million - $6.95 Million	-18,900 Reduced 34.87%	35,300 $9.67 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $3.85 Million - $4.31 Million	-12,500 Reduced 18.74%	54,200 $17.3 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $18.8 Million - $22 Million	66,700	66,700 $20.9 Million

1,050

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $27.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.